- Home
- GXAI vs DSS Comparison
GXAI vs DSS Comparison
Compare GXAI & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GXAI
- DSS
- Stock Information
- Founded
- GXAI 2021
- DSS 1984
- Country
- GXAI United States
- DSS United States
- Employees
- GXAI N/A
- DSS N/A
- Industry
- GXAI
- DSS Containers/Packaging
- Sector
- GXAI
- DSS Consumer Discretionary
- Exchange
- GXAI Nasdaq
- DSS Nasdaq
- Market Cap
- GXAI 19.7M
- DSS 11.6M
- IPO Year
- GXAI 2023
- DSS N/A
- Fundamental
- Price
- GXAI $1.72
- DSS $1.28
- Analyst Decision
- GXAI
- DSS
- Analyst Count
- GXAI 0
- DSS 0
- Target Price
- GXAI N/A
- DSS N/A
- AVG Volume (30 Days)
- GXAI 15.2M
- DSS 788.2K
- Earning Date
- GXAI 11-13-2025
- DSS 11-12-2025
- Dividend Yield
- GXAI N/A
- DSS N/A
- EPS Growth
- GXAI N/A
- DSS N/A
- EPS
- GXAI N/A
- DSS N/A
- Revenue
- GXAI $198,711.00
- DSS $21,252,000.00
- Revenue This Year
- GXAI N/A
- DSS N/A
- Revenue Next Year
- GXAI N/A
- DSS N/A
- P/E Ratio
- GXAI N/A
- DSS N/A
- Revenue Growth
- GXAI 72158.55
- DSS 10.24
- 52 Week Low
- GXAI $1.00
- DSS $0.72
- 52 Week High
- GXAI $7.50
- DSS $1.90
- Technical
- Relative Strength Index (RSI)
- GXAI 54.22
- DSS 56.02
- Support Level
- GXAI $1.41
- DSS $1.10
- Resistance Level
- GXAI $1.85
- DSS $1.44
- Average True Range (ATR)
- GXAI 0.20
- DSS 0.24
- MACD
- GXAI -0.03
- DSS -0.00
- Stochastic Oscillator
- GXAI 32.98
- DSS 41.80
About GXAI Gaxos.ai Inc.
Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.
About DSS DSS Inc.
DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia. Product packaging manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the securities trading and/or fund management arena.